{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:21:50Z","timestamp":1770974510063,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100326"],"award-info":[{"award-number":["81100326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31402204"],"award-info":[{"award-number":["31402204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2012M520684"],"award-info":[{"award-number":["2012M520684"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015T80311"],"award-info":[{"award-number":["2015T80311"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Postdoctoral Science Foundation","award":["801130020428"],"award-info":[{"award-number":["801130020428"]}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20170101147JC"],"award-info":[{"award-number":["20170101147JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cellimm.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T17:01:02Z","timestamp":1496854862000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The combination of NK and CD8+ T cells with CCL20\/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells"],"prefix":"10.1016","volume":"318","author":[{"given":"Jun-feng","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-xi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2017.06.002_b0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2017.06.002_b0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","article-title":"Adoptive immunotherapy for cancer: building on success","volume":"6","author":"Gattinoni","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0015","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.3390\/ijms150814632","article-title":"Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies","volume":"15","author":"Schmeel","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2017.06.002_b0020","doi-asserted-by":"crossref","first-page":"e44802","DOI":"10.1371\/journal.pone.0044802","article-title":"Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2017.06.002_b0025","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.intimp.2016.06.028","article-title":"Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21\/IL15 armed oncolytic adenovirus in TERT-positive tumor cells","volume":"38","author":"Ye","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0030","doi-asserted-by":"crossref","first-page":"e78980","DOI":"10.1371\/journal.pone.0078980","article-title":"Sunitinib indirectly enhanced anti-tumor cytotoxicity of cytokine-induced killer cells and CD3+CD56+ subset through the co-culturing dendritic cells","volume":"8","author":"Wongkajornsilp","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2017.06.002_b0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.intimp.2014.07.019","article-title":"Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis","volume":"22","author":"Chen","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7150\/jca.2.363","article-title":"Cytokine induced killer cells as promising immunotherapy for solid tumors","volume":"2","author":"Sangiolo","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.cellimm.2017.06.002_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","article-title":"Combining immunotherapy and targeted therapies in cancer treatment","volume":"12","author":"Vanneman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellimm.2017.06.002_b0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-59745-237-3_15","article-title":"Oncolytic adenoviruses for cancer gene therapy","volume":"433","author":"Liu","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.virusres.2016.05.002","article-title":"CCL21\/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells","volume":"220","author":"Li","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.cellimm.2017.06.002_b0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cellimm.2014.03.020","article-title":"Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas","volume":"289","author":"Zhao","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0065","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1038\/sj.onc.1209044","article-title":"Oncolytic adenoviruses-selective retargeting to tumor cells","volume":"24","author":"Mathis","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2017.06.002_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-31-51","article-title":"Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo","volume":"31","author":"Zhu","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2017.06.002_b0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.cgt.7701105","article-title":"A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes","volume":"3","author":"Hu","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.cellimm.2017.06.002_b0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.intimp.2015.07.005","article-title":"Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L","volume":"28","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.imbio.2014.02.009","article-title":"Adenovirus-mediated CCL20\/IL-15 gene transfer enhances antitumor immunity in mice","volume":"219","author":"Liu","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2017.06.002_b0090","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cellimm.2017.06.002_b0095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-60761-974-1_20","article-title":"Adenovirus-mediated gene transfer","volume":"693","author":"van-Dijk","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2217\/imt.10.107","article-title":"Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy","volume":"3","author":"Barsov","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.cellimm.2017.06.002_b0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.celrep.2016.03.017","article-title":"Manipulating TLR signaling increases the anti-tumor T cell response induced by viral cancer therapies","volume":"15","author":"Rojas","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2017.06.002_b0110","first-page":"10","article-title":"CCL21 chemokine therapy for lung cancer","volume":"1","author":"Sharma","year":"2013","journal-title":"Int. Trends Immun."},{"key":"10.1016\/j.cellimm.2017.06.002_b0115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200419762","article-title":"Induction of potent antitumor immunity by in situ targeting of intratumoral DCs","volume":"113","author":"Furumoto","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2017.06.002_b0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/mt.2011.57","article-title":"Engineering dendritic cells to enhance cancer immunotherapy","volume":"19","author":"Boudreau","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellimm.2017.06.002_b0125","first-page":"481","article-title":"Combination immune therapies to enhance anti-tumor responses by NK cells","volume":"4","author":"James","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2017.06.002_b0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2007.02719.x","article-title":"Immunological decision-making: how does the immune system decide to mount a helper T-cell response?","volume":"123","author":"Kaiko","year":"2008","journal-title":"Immunology"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874917300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874917300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:56:14Z","timestamp":1757804174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874917300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":26,"alternative-id":["S0008874917300928"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2017.06.002","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of NK and CD8+T cells with CCL20\/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}